Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
| dc.contributor.author | Schmalbach, Cecelia E. | |
| dc.contributor.author | Bradford, Carol R. | |
| dc.contributor.department | Otolaryngology -- Head and Neck Surgery, School of Medicine | en_US |
| dc.date.accessioned | 2018-06-29T14:23:44Z | |
| dc.date.available | 2018-06-29T14:23:44Z | |
| dc.date.issued | 2018-02-05 | |
| dc.description.abstract | The application and utility of melanoma sentinel lymph node biopsy (SLNB) has evolved significantly since its inception over two decades ago. The current focus has shifted from a staging modality to potentially a therapeutic intervention. Recent research to include large multi-institutional randomized trials have attempted to answer the question: is a completion lymph node dissection (CLND) required following a positive SLNB? This review provides an evidence-based, contemporary review of the utility of CLND for SLNB positive head and neck cutaneous melanoma patients. | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Schmalbach, C. E., & Bradford, C. R. (2018). Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma. Laryngoscope Investigative Otolaryngology, 3(1), 43–48. http://doi.org/10.1002/lio2.136 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/16605 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1002/lio2.136 | en_US |
| dc.relation.journal | Laryngoscope Investigative Otolaryngology | en_US |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.source | PMC | en_US |
| dc.subject | Melanoma | en_US |
| dc.subject | Completion lymphadenectomy | en_US |
| dc.subject | Sentinel node biopsy | en_US |
| dc.title | Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma | en_US |
| dc.type | Article | en_US |